ALLYSON MILLS: Open Payments
NPI 1811398829 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$947 in 48 payments from 13 companies in 2025. Trend: 2023 $1,296 · 2024 $1,292 · 2025 $947
Food & beverage: $947
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $226 |
| Amgen Inc. | 12 | $179 |
| UCB, Inc. | 5 | $130 |
| PFIZER INC. | 4 | $79 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| Radius Health, Inc. | 1 | $60 |
| Sandoz Inc. | 2 | $48 |
| Janssen Biotech, Inc. | 2 | $39 |
| Organon LLC | 2 | $26 |
| Genentech USA, Inc. | 1 | $26 |
Products named: Bimzelx, RINVOQ, SKYRIZI, TAVNEOS, XELJANZ, ENBREL, Tymlos, HYRIMOZ.
Industry payments across IN — which companies pay providers there.
